HIINX
Price
$57.59
Change
+$0.31 (+0.54%)
Updated
Jun 2 closing price
Net Assets
3.81B
VTISX
Price
$196.90
Change
+$1.20 (+0.61%)
Updated
Jun 2 closing price
Net Assets
629.15B
Interact to see
Advertisement

HIINX vs VTISX

Header iconHIINX vs VTISX Comparison
Open Charts HIINX vs VTISXBanner chart's image
HIINX vs VTISX Comparison Chart in %
View a ticker or compare two or three
VS
HIINX vs. VTISX commentary
Jun 04, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is HIINX is a Buy and VTISX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VTISX has more cash in the bank: 629B vs. HIINX (3.81B). HIINX pays higher dividends than VTISX: HIINX (3.08) vs VTISX (2.66). HIINX was incepted earlier than VTISX: HIINX (24 years) vs VTISX (10 years). HIINX (1.23) is less costly to investors than VTISX (0.05). HIINX is a more actively managed with annual turnover of: 17.00 vs. VTISX (4.00). HIINX has a lower initial minimum investment than VTISX: HIINX (2500) vs VTISX (3000000000). VTISX annual gain was more profitable for investors over the last year : 29.05 vs. HIINX (14.74). VTISX return over 5 years is better than : 35.36 vs. HIINX (32.28).
HIINXVTISXHIINX / VTISX
Total Expense Ratio1.140.052,478%
Annual Report Gross Expense Ratio1.230.052,674%
Fund Existence24 years10 years-
Gain YTD5.33314.64836%
Front LoadN/AN/A-
Min. Initial Investment250030000000000%
Min. Initial Investment IRAN/AN/A-
Net Assets3.81B629B1%
Annual Yield % from dividends3.082.66116%
Returns for 1 year14.7429.0551%
Returns for 3 years48.3159.5781%
Returns for 5 years32.2835.3691%
Returns for 10 years9.63106.559%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AUR7.710.24
+3.21%
Aurora Innovation
PARK19.960.19
+0.98%
Park Dental Partners Inc.
HUN14.99-0.01
-0.07%
Huntsman Corp
ZNB1.74-0.03
-1.69%
Zeta Network Group
GYRE5.59-0.22
-3.79%
Gyre Therapeutics